LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 41

Search options

  1. Article: Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines.

    Manners, Christopher / Larios Bautista, Erick / Sidoti, Hannah / Lopez, Osvaldo J

    Cureus

    2020  Volume 12, Issue 6, Page(s) e8399

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging human coronavirus responsible for coronavirus disease 2019 (COVID-19), a predominantly respiratory disease that has become a global pandemic. Millions of people worldwide are ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging human coronavirus responsible for coronavirus disease 2019 (COVID-19), a predominantly respiratory disease that has become a global pandemic. Millions of people worldwide are suffering from COVID-19, and hundreds of thousands of those infected have died. Nevertheless, many more people who have been infected with SARS-CoV-2 are asymptomatic or suffer a mild disease characterized by dry cough and mild fever. This new pandemic poses a threat to public health on a global scale, and an intervention to prevent continued spread of SARS-CoV-2 virus is of the utmost importance. To assess preventive and therapeutic strategies, it is imperative to understand the pathogenesis and immune response against SARS-CoV-2. In this review, we concentrate on the protective adaptive immune response elicited by this novel coronavirus as well as requirements for a successful vaccine inducing optimal protection.
    Keywords covid19
    Language English
    Publishing date 2020-06-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2747273-5
    ISSN 2168-8184
    ISSN 2168-8184
    DOI 10.7759/cureus.8399
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: m

    Manners, Oliver / Baquero-Perez, Belinda / Mottram, Timothy J / Yonchev, Ivaylo D / Trevelyan, Christopher J / Harper, Katherine L / Menezes, Sarah / Patterson, Molly R / Macdonald, Andrew / Wilson, Stuart A / Aspden, Julie L / Whitehouse, Adrian

    Viruses

    2023  Volume 15, Issue 6

    Abstract: The epitranscriptomic ... ...

    Abstract The epitranscriptomic modification
    MeSH term(s) Herpesvirus 8, Human/genetics ; Virus Latency/genetics ; Cell Line, Tumor ; Signal Transduction ; RNA, Messenger/genetics ; Virus Replication ; Gene Expression Regulation, Viral
    Chemical Substances RNA, Messenger
    Language English
    Publishing date 2023-06-16
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v15061381
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

    Pucci, Perla / Lee, Liam C / Han, Miaojun / Matthews, Jamie D / Jahangiri, Leila / Schlederer, Michaela / Manners, Eleanor / Sorby-Adams, Annabel / Kaggie, Joshua / Trigg, Ricky M / Steel, Christopher / Hare, Lucy / James, Emily R / Prokoph, Nina / Ducray, Stephen P / Merkel, Olaf / Rifatbegovic, Firkret / Luo, Ji / Taschner-Mandl, Sabine /
    Kenner, Lukas / Burke, G A Amos / Turner, Suzanne D

    Nature communications

    2024  Volume 15, Issue 1, Page(s) 3422

    Abstract: Targeting Anaplastic lymphoma kinase (ALK) is a promising therapeutic strategy for aberrant ALK-expressing malignancies including neuroblastoma, but resistance to ALK tyrosine kinase inhibitors (ALK TKI) is a distinct possibility necessitating drug ... ...

    Abstract Targeting Anaplastic lymphoma kinase (ALK) is a promising therapeutic strategy for aberrant ALK-expressing malignancies including neuroblastoma, but resistance to ALK tyrosine kinase inhibitors (ALK TKI) is a distinct possibility necessitating drug combination therapeutic approaches. Using high-throughput, genome-wide CRISPR-Cas9 knockout screens, we identify miR-1304-5p loss as a desensitizer to ALK TKIs in aberrant ALK-expressing neuroblastoma; inhibition of miR-1304-5p decreases, while mimics of this miRNA increase the sensitivity of neuroblastoma cells to ALK TKIs. We show that miR-1304-5p targets NRAS, decreasing cell viability via induction of apoptosis. It follows that the farnesyltransferase inhibitor (FTI) lonafarnib in addition to ALK TKIs act synergistically in neuroblastoma, inducing apoptosis in vitro. In particular, on combined treatment of neuroblastoma patient derived xenografts with an FTI and an ALK TKI complete regression of tumour growth is observed although tumours rapidly regrow on cessation of therapy. Overall, our data suggests that combined use of ALK TKIs and FTIs, constitutes a therapeutic approach to treat high risk neuroblastoma although prolonged therapy is likely required to prevent relapse.
    MeSH term(s) Animals ; Female ; Humans ; Mice ; Anaplastic Lymphoma Kinase/genetics ; Anaplastic Lymphoma Kinase/metabolism ; Anaplastic Lymphoma Kinase/antagonists & inhibitors ; Apoptosis/drug effects ; Apoptosis/genetics ; Cell Line, Tumor ; Dibenzocycloheptenes ; Drug Resistance, Neoplasm/genetics ; Drug Resistance, Neoplasm/drug effects ; Drug Synergism ; Farnesyltranstransferase/antagonists & inhibitors ; Farnesyltranstransferase/metabolism ; Gene Expression Regulation, Neoplastic/drug effects ; GTP Phosphohydrolases/genetics ; GTP Phosphohydrolases/metabolism ; Membrane Proteins/metabolism ; Membrane Proteins/genetics ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Mutation ; Neuroblastoma/drug therapy ; Neuroblastoma/genetics ; Neuroblastoma/pathology ; Neuroblastoma/metabolism ; Piperidines/pharmacology ; Piperidines/therapeutic use ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Xenograft Model Antitumor Assays
    Chemical Substances ALK protein, human (EC 2.7.10.1) ; Anaplastic Lymphoma Kinase (EC 2.7.10.1) ; Dibenzocycloheptenes ; Farnesyltranstransferase (EC 2.5.1.29) ; GTP Phosphohydrolases (EC 3.6.1.-) ; lonafarnib (IOW153004F) ; Membrane Proteins ; MicroRNAs ; NRAS protein, human (EC 3.6.1.-) ; Piperidines ; Protein Kinase Inhibitors ; Pyridines
    Language English
    Publishing date 2024-04-23
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-024-47771-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Protective Adaptive Immunity Against Severe Acute Respiratory Syndrome Coronaviruses 2 (SARS-CoV-2) and Implications for Vaccines

    Manners, Christopher / Larios Bautista, Erick / Sidoti, Hannah / Lopez, Osvaldo J.

    Cureus

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging human coronavirus responsible for coronavirus disease 2019 (COVID-19), a predominantly respiratory disease that has become a global pandemic Millions of people worldwide are ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging human coronavirus responsible for coronavirus disease 2019 (COVID-19), a predominantly respiratory disease that has become a global pandemic Millions of people worldwide are suffering from COVID-19, and hundreds of thousands of those infected have died Nevertheless, many more people who have been infected with SARS-CoV-2 are asymptomatic or suffer a mild disease characterized by dry cough and mild fever This new pandemic poses a threat to public health on a global scale, and an intervention to prevent continued spread of SARS-CoV-2 virus is of the utmost importance To assess preventive and therapeutic strategies, it is imperative to understand the pathogenesis and immune response against SARS-CoV-2 In this review, we concentrate on the protective adaptive immune response elicited by this novel coronavirus as well as requirements for a successful vaccine inducing optimal protection
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #540107
    Database COVID19

    Kategorien

  5. Article ; Online: Steroid Therapy and Outcome of Parapneumonic Pleural Effusions (STOPPE): A Pilot Randomized Clinical Trial.

    Fitzgerald, Deirdre B / Waterer, Grant W / Budgeon, Charley / Shrestha, Ranjan / Fysh, Edward T / Muruganandan, Sanjeevan / Stanley, Christopher / Saghaie, Tajalli / Badiei, Arash / Sidhu, Calvin / Harryanto, Hilman / Duong, Victor / Azzopardi, Maree / Manners, David / Lan, Norris S H / Popowicz, Natalia D / Peddle-McIntyre, Carolyn J / Rahman, Najib M / Read, Catherine A /
    Tan, Ai Ling / Gan, Seng Khee / Murray, Kevin / Lee, Y C Gary

    American journal of respiratory and critical care medicine

    2022  Volume 205, Issue 9, Page(s) 1093–1101

    Abstract: Rationale: ...

    Abstract Rationale:
    MeSH term(s) Adrenal Cortex Hormones/therapeutic use ; Adult ; Australia ; Community-Acquired Infections/complications ; Community-Acquired Infections/drug therapy ; Dexamethasone/therapeutic use ; Humans ; Pilot Projects ; Pleural Effusion/drug therapy ; Pneumonia/complications ; Steroids/therapeutic use
    Chemical Substances Adrenal Cortex Hormones ; Steroids ; Dexamethasone (7S5I7G3JQL)
    Language English
    Publishing date 2022-01-26
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202107-1600OC
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Recurrent Optic Disc Hemorrhage and Its Association with Visual Field Deterioration in Glaucoma.

    An, Dong / House, Philip / Barry, Christopher / Turpin, Andrew / McKendrick, Allison M / Chauhan, Balwantray C / Manners, Siobhan / Graham, Stuart / Yu, Dao-Yi / Morgan, William H

    Ophthalmology. Glaucoma

    2020  Volume 3, Issue 6, Page(s) 443–452

    Abstract: Purpose: To investigate the association among optic disc hemorrhage (ODH) recurrence, location, and visual field (VF) progression.: Design: Prospective, observational study.: Participants: Patients with bilateral glaucoma or unilateral glaucoma ... ...

    Abstract Purpose: To investigate the association among optic disc hemorrhage (ODH) recurrence, location, and visual field (VF) progression.
    Design: Prospective, observational study.
    Participants: Patients with bilateral glaucoma or unilateral glaucoma with a fellow glaucoma suspect eye were enrolled.
    Methods: Patients received optic disc photography every 3 months and VF testing every 4 months. The disc was partitioned into 8 sectors to match 8 visual field (VF) sectors. The frequency of ODH in each sector was quantified over an average of 64 months. Global VF progression rate was calculated using linear regression on mean deviation. Sectoral progression rate was calculated using linear regression on the sensitivity at each VF location over time and then selecting the largest and second largest significant (P < 0.05) negative slope within that sector. The association between ODH and VF progression rate globally and within a sector was calculated using linear mixed modeling.
    Main outcome measures: Global and sectoral VF progression, ODH frequency, and ODH recurrence (globally and sectoral) and its association with VF progression rate.
    Results: A total of 151 eyes from 77 patients completed the study with mean follow-up of 64 months, 20 disc photographs, and 16 VF tests. With global VF analysis, eyes with ODH in 2 different sectors of the disc had worse progression rate than eyes with ODH in 1 sector (P = 0.012) and eyes with no ODH (P < 0.001). Regarding the largest sectoral VF progression, sectors with 1 ODH had a faster VF progression rate than those with no ODH (P < 0.017) and progressed at a similar rate to those with 2 to 8 ODH (P = 0.592). Sectors with >8 ODH had faster VF progression than all other groups (all P < 0.001).
    Conclusions: High-frequency ODH within optic disc sectors, equivalent to detecting ODH in 45% of 3 monthly eye examination visits, was associated with significantly worse VF progression than sectors with moderate or only 1 observed ODH. In addition, ODH occurring in different sectors in the same eye was more strongly associated with greater global VF progression compared with those occurring within the same sector.
    MeSH term(s) Aged ; Disease Progression ; Female ; Glaucoma/complications ; Glaucoma/diagnosis ; Glaucoma/physiopathology ; Humans ; Intraocular Pressure/physiology ; Male ; Optic Disk/blood supply ; Optic Nerve Diseases/diagnosis ; Optic Nerve Diseases/etiology ; Prospective Studies ; Retinal Hemorrhage/diagnosis ; Retinal Hemorrhage/etiology ; Tomography, Optical Coherence/methods ; Visual Fields/physiology
    Language English
    Publishing date 2020-06-09
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
    ISSN 2589-4196
    ISSN (online) 2589-4196
    DOI 10.1016/j.ogla.2020.06.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Decompression alone vs. decompression plus fusion for claudication secondary to lumbar spinal stenosis.

    Thomas, Kenneth / Faris, Peter / McIntosh, Greg / Manners, Simon / Abraham, Edward / Bailey, Christopher S / Paquet, Jerome / Cadotte, David / Jacobs, W Bradley / Rampersaud, Y Raja / Manson, Neil A / Hall, Hamilton / Fisher, Charles G

    The spine journal : official journal of the North American Spine Society

    2019  Volume 19, Issue 10, Page(s) 1633–1639

    Abstract: Background: Degenerative lumbar spinal stenosis is a common condition, predominantly affecting middle-aged and elderly people. This study focused on patients with neurogenic claudication secondary to lumbar stenosis without spondylolisthesis or ... ...

    Abstract Background: Degenerative lumbar spinal stenosis is a common condition, predominantly affecting middle-aged and elderly people. This study focused on patients with neurogenic claudication secondary to lumbar stenosis without spondylolisthesis or deformity.
    Purpose: To determine whether the addition of fusion to decompression resulted in improved clinical outcomes at 3, 12, and 24 months postsurgery.
    Study design/setting: The Canadian Spine Outcomes and Research Network (CSORN) prospective database that includes pre- and postoperative data from tertiary care hospitals.
    Patient sample: The CSORN database was queried for consecutive spine surgery cases of degenerative lumbar stenosis receiving surgical decompression for neurogenic claudication or radiculopathy. Neurogenic claudication patients with baseline and 2-year follow-up data, from four sites, formed the study sample (n=306). The sample was categorized into two groups: (1) those that had decompression alone, and (2) those that underwent decompression plus fusion.
    Outcome measures: Change in modified Oswestry Disability Index (ODI), numerical rating scale for back/leg pain, the EuroQol EQ5D, the SF-12 physical, and mental component scores. The primary outcome measure was the ODI at 2 years postoperative.
    Methods: We conducted a multicenter, ambispective review of consecutive spine surgery patients enrolled between October 2012 and January 2018.
    Results: Baseline characteristics were comparable between groups except for female sex and multilevel pathology (both with greater proportion in the decompression plus fusion group). The decompression plus fusion group had clinically meaningfully more operative time, blood loss, rate of perioperative complication, and length of hospital stay (p<.05). These differences were preserved following adjustment for baseline differences between the groups. Both decompression and decompression plus fusion had a large clinically meaningful impact on generic and disease-specific patient-reported outcome measures within 3 months of surgery which was maintained out to 24-month follow-up. At any follow-up time point, there was no statistical evidence of a difference in these effects favoring decompression plus fusion over decompression alone.
    Conclusions: The addition of fusion to decompression did not result in improved outcomes at 3-, 12-, or 24-month follow-up. The addition of fusion to decompression provides no advantage to decompression alone for the treatment of patients with neurogenic claudication secondary to lumbar stenosis without spondylolisthesis or deformity.
    MeSH term(s) Aged ; Decompression, Surgical/adverse effects ; Decompression, Surgical/methods ; Female ; Gait ; Humans ; Intermittent Claudication/etiology ; Intermittent Claudication/surgery ; Lumbar Vertebrae/surgery ; Male ; Middle Aged ; Patient Reported Outcome Measures ; Postoperative Complications/epidemiology ; Spinal Stenosis/complications ; Spinal Stenosis/surgery
    Language English
    Publishing date 2019-06-10
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 2037072-6
    ISSN 1878-1632 ; 1529-9430
    ISSN (online) 1878-1632
    ISSN 1529-9430
    DOI 10.1016/j.spinee.2019.06.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Polyaminoborane main chain scission using N-heterocyclic carbenes; formation of donor-stabilised monomeric aminoboranes.

    Stubbs, Naomi E / Jurca, Titel / Leitao, Erin M / Woodall, Christopher H / Manners, Ian

    Chemical communications (Cambridge, England)

    2013  Volume 49, Issue 80, Page(s) 9098–9100

    Abstract: The reaction of N-heterocyclic carbenes with polyaminoboranes [MeNH-BH2]n or [NH2-BH2]n at 20 °C led to depolymerisation and the formation of labile, monomeric aminoborane-NHC adducts, RNH-BH2-NHC (R = Me or H); a similar NHC adduct of Ph2N=BCl2 was ... ...

    Abstract The reaction of N-heterocyclic carbenes with polyaminoboranes [MeNH-BH2]n or [NH2-BH2]n at 20 °C led to depolymerisation and the formation of labile, monomeric aminoborane-NHC adducts, RNH-BH2-NHC (R = Me or H); a similar NHC adduct of Ph2N=BCl2 was characterized by single crystal X-ray diffraction.
    Language English
    Publishing date 2013-10-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 1472881-3
    ISSN 1364-548X ; 1359-7345 ; 0009-241X
    ISSN (online) 1364-548X
    ISSN 1359-7345 ; 0009-241X
    DOI 10.1039/c3cc44373f
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Low rates of eligibility for lung cancer screening in patients undergoing computed tomography coronary angiography.

    Lyne, Christopher / Zaw, Shane / King, Bridget / See, Katharine / Manners, David / Al-Kaisey, Ahmed / Joshi, Subodh / Farouque, Omar / Irving, Louis / Johnson, Douglas / Steinfort, Daniel

    Internal medicine journal

    2018  Volume 48, Issue 10, Page(s) 1265–1268

    Abstract: Incidental findings, including pulmonary nodules, on computed tomography coronary angiography (CTCA) are common. Previous authors have suggested CTCA could allow opportunistic screening for lung cancer, though the lung cancer risk profile of this patient ...

    Abstract Incidental findings, including pulmonary nodules, on computed tomography coronary angiography (CTCA) are common. Previous authors have suggested CTCA could allow opportunistic screening for lung cancer, though the lung cancer risk profile of this patient group has not previously been established. Smoking histories of 229 patients undergoing CTCA at two tertiary hospitals were reviewed and only 25% were current or former smokers aged 55-80 years old. Less than half of this group were eligible for screening based on the PLCO
    MeSH term(s) Aged ; Australia/epidemiology ; Coronary Angiography ; Cross-Sectional Studies ; Early Detection of Cancer/statistics & numerical data ; Eligibility Determination/statistics & numerical data ; Female ; Humans ; Incidental Findings ; Lung Neoplasms/diagnostic imaging ; Male ; Mass Screening ; Middle Aged ; Multiple Pulmonary Nodules/diagnostic imaging ; Smoking/epidemiology ; Tomography, X-Ray Computed
    Language English
    Publishing date 2018-10-04
    Publishing country Australia
    Document type Journal Article
    ZDB-ID 2045436-3
    ISSN 1445-5994 ; 1444-0903
    ISSN (online) 1445-5994
    ISSN 1444-0903
    DOI 10.1111/imj.14061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Homogeneous, titanocene-catalyzed dehydrocoupling of amine-borane adducts.

    Clark, Timothy J / Russell, Christopher A / Manners, Ian

    Journal of the American Chemical Society

    2006  Volume 128, Issue 30, Page(s) 9582–9583

    Abstract: Transition metal catalysis represents a relatively unexplored but potentially useful route to form bonds between main group elements. Previous work in the area of amine-borane adduct dehydrocoupling has exclusively employed late transition metal (e.g., ... ...

    Abstract Transition metal catalysis represents a relatively unexplored but potentially useful route to form bonds between main group elements. Previous work in the area of amine-borane adduct dehydrocoupling has exclusively employed late transition metal (e.g., Rh) catalysts which were found to predominantly operate via a heterogeneous mechanism. Herein, we present a new, early transition-metal-catalyzed, homogeneous system which exhibits higher activity.
    Language English
    Publishing date 2006-08-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3155-0
    ISSN 1520-5126 ; 0002-7863
    ISSN (online) 1520-5126
    ISSN 0002-7863
    DOI 10.1021/ja062217k
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top